Difference between revisions of "Stub"
Jump to navigation
Jump to search
(Created page with "Regimens that have not proven to be superior to a standard-of-care comparison and are thus unlikely to be expanded upon. This page is primarily to drive the Ontology. ==T...") |
m (→TG+Bev) |
||
| Line 1: | Line 1: | ||
Regimens that have not proven to be superior to a standard-of-care comparison and are thus unlikely to be expanded upon. This page is primarily to drive the [[Ontology]]. | Regimens that have not proven to be superior to a standard-of-care comparison and are thus unlikely to be expanded upon. This page is primarily to drive the [[Ontology]]. | ||
| + | |||
| + | ==Ixabepilone & Bevacizumab== | ||
| + | {| class="wikitable" style="float:right; margin-left: 5px;" | ||
| + | |- | ||
| + | |[[#top|back to top]] | ||
| + | |} | ||
| + | ===Regimen=== | ||
| + | ====Chemotherapy==== | ||
| + | *[[Ixabepilone (Ixempra)]] | ||
| + | ====Targeted therapy==== | ||
| + | *[[Bevacizumab (Avastin)]] | ||
==TG+Bev== | ==TG+Bev== | ||
Revision as of 19:35, 25 July 2020
Regimens that have not proven to be superior to a standard-of-care comparison and are thus unlikely to be expanded upon. This page is primarily to drive the Ontology.
Ixabepilone & Bevacizumab
| back to top |
Regimen
Chemotherapy
Targeted therapy
TG+Bev
| back to top |
TG+Bev: Taxotere (Docetaxel), Gemcitabine, Bevacizumab
Regimen
Chemotherapy
Targeted therapy
TX+Bev
| back to top |
TX+Bev: Taxotere (Docetaxel), Xeloda (Capecitabine), Bevacizumab